Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2023-11-02 00:00:00 ET · period of report 2023-10-31 · accession 0001801170-23-000089 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-02 | 2023-10-31 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | CTO | A - Grant | $0.00 | +440.0K | 3.09M | +17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-10-31 | A | A | 440,000 | $0.00 | 3,093,225 | D | — | — | (F1) Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Fifty percent of the RSUs will vest on the first anniversary of October 31, 2023, and the remaining RSUs will vest in four equal quarterly installments beginning on the date that is three months after the first anniversary of October 31, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 31, 2025. |